Corpus Intelligence IC Memo — LOMPOC VALLEY MEDICAL CENTER 2026-04-26 09:39 UTC
IC Memo — LOMPOC VALLEY MEDICAL CENTER
Investment Committee Memorandum | CA | 60 beds | Grade C | EBITDA uplift $10.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LOMPOC VALLEY MEDICAL CENTER

CCN 050110 | SANTA BARBARA, CA | 60 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LOMPOC VALLEY MEDICAL CENTER is a 60-bed community hospital in SANTA BARBARA, CA with $140.5M in net patient revenue and a -6.2% operating margin. The hospital serves a payer mix of 47.9% Medicare, 0.0% Medicaid, and 52.1% commercial.

Thesis: Turnaround. Our ML models identify $10.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.2% to 1.2% (+736bps).

Net Revenue HCRIS$140.5M
Current EBITDA COMPUTED$-8.7M
Operating Margin COMPUTED-6.2%
Occupancy HCRIS43.7%
Revenue / Bed COMPUTED$2.3M
Net-to-Gross HCRIS44.8%
Distress Probability MLnan%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
124
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -6.2% places it below the state median. Among 124 size-comparable peers (30-120 beds), the median margin is -6.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (30-120), prioritizing same-state peers. 124 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LOMPOC VALLEY MEDICAL CENTER (Target)CA60$140.5M-6.2%
RANCHO LOS AMIGOS NATL.REHAB.CCA83$512.6M41.9%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%
KFH - FREMONTCA100$296.2M-6.6%
QUEEN OF THE VALLEY MEDICAL CECA119$293.8M-16.7%
MERCY HOSPITAL OF FOLSOMCA106$287.8M17.0%
MARSHALL HOSPITALCA111$286.0M-5.9%
KFH - SOUTH SAN FRANCISCOCA120$284.6M-0.0%
LLUMC MURRIETACA111$276.7M-20.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.0M+210bp18mo
Cost to Collect4.5%2.5%$2.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.7M+122bp9mo
Clean Claim Rate88.0%96.0%$90K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.0M
Cost to Collect
$2.8M
Denial Rate Reduction
$2.8M
A/R Days Reduction
$1.7M
Clean Claim Rate
$90K
Total EBITDA Uplift$10.3M
Current EBITDA$-8.7M
+ RCM Uplift+$10.3M
Pro Forma EBITDA$1.7M
Current Margin-6.2%
Pro Forma Margin1.2%
WC Released (1x)$5.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-13.3M$46.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-13.3M$46.5M0.00x-100.0%
Bull Case9.0x11.0x$-12.0M$76.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-12.0M$79.7M0.00x-100.0%
Bear Case11.0x10.0x$-14.7M$-1.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-14.7M$-6.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 124 hospitals with 30-120 beds
  • Same-state prioritization (n=125)
  • Comp margins: P25=-23.8% / P50=-6.6% / P75=1.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.